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Previous studies have examined exposures to
daily maximum temperatures and air pollu-
tant concentrations during the warm summer
months of July and August in Tokyo and
their effect on the daily number of hospital
emergency transports per million for heat
stroke (1) and three cerebral vascular diseases:
cerebral hemorrhage, cerebral infarction, and
cerebral ischemia (2). Both studies indicated
that males and females > 65 years of age had
the highest daily number of heat stroke and
cerebral vascular disease hospital emergency
transports per million of any age group to
four Tokyo city hospitals. For heat stroke,
exposures to daily maximum temperatures
(Tmax) and concentrations of nitrogen diox-
ide were associated with the daily number of
hospital emergency transports per million
residents. Exposures to higher Tmax were
associated with a decrease in the daily num-
ber of hospital emergency transports per mil-
lion residents for cerebral hemorrhage. For
cerebral infarction, hospital emergency trans-
ports per million were associated with
increasing daily average NO2 concentrations.
For cerebral ischemia, exposures to Tmax and
daily average ozone concentrations were asso-
ciated with the daily hospital emergency
transports per million residents.
For these four diseases, it was evident that
increasing or decreasing numbers of hospital
emergency transports per million were not
associated with the same set of temperature
and air pollutant variables. Therefore, addi-
tional studies to examine hospital emergency
transports for other diseases as functions of
daily maximum temperatures and air pollu-
tant concentrations needed to be conducted
on a disease-by-disease basis.
The studies on cardiovascular and respi-
ratory diseases in Tokyo were undertaken
because in the next 50–100 years, there could
be a doubling of atmospheric concentrations
of carbon dioxide (3). This could raise sur-
face temperatures year-round by 1–3°C and
result in a greater frequency and longer dura-
tion of heat waves during warmer months of
the year not only in Tokyo but in many
other major urban areas worldwide. Also the
number of people > 65 years of age in Tokyo
is increasing (4), and this population appears
to be most vulnerable to higher temperatures
and higher air pollutant concentrations. 
The months of July and August in
Tokyo are when daily maximum tempera-
tures are the highest and when many air pol-
lutants have high concentrations because of
atmospheric chemical and photochemical
reactions and meteorological conditions that
cause air pollutant concentrations to be high
at ground level, especially in large, urban
areas. Therefore, months of the year were
selected when the frequency of exposures to
both higher daily maximum temperatures
and air pollutant concentrations would be
the greatest.
The covariates that were used to deter-
mine if temperature or air quality may be
associated with each cardiovascular and respi-
ratory disease were Tmax and air pollutant
concentrations for NO2, O3, sulfur dioxide,
carbon monoxide, and particles with aerody-
namic diameters ≤ 10 µm (PM10). We chose
Tmax temperatures over average daily temper-
atures (Tav), and minimum daily tempera-
tures (Tmin), because Tmax temperatures
represented the maximum levels of heat stress
that could occur on a daily basis. Tmax was
also selected over the heat index because Tmax
can be more directly associated with core
body temperatures. The heat index is not a
temperature and is calculated from a complex
polynomial expression for temperature and
relative humidity that makes it difficult to
separate the temperature contribution from
the relative humidity contribution. The car-
diovascular diseases that were examined and
their International Classiﬁcation of Disease, 9th
Revision (ICD-9) codes included hypertension
(ICD-9 codes 401–405), myocardial infarc-
tion (ICD-9 code 410), angina (ICD-9 code
413), and cardiac insufﬁciency (ICD-9 code
428). The respiratory diseases included acute
bronchitis (ICD-9 code 466), pneumonia
(ICD-9 code 486), chronic bronchitis (ICD-
9 code 491), and asthma (ICD-9 code 493).
There is an extensive literature about the
association between daily mortality and hos-
pital admissions for cardiovascular and respi-
ratory diseases and daily changes in air
pollutant concentrations and climate vari-
ables (5–36). This literature was important in
selecting variables that may affect hospital
emergency transports in Tokyo. Exposures to
air pollutants have been associated with dam-
age to lung tissues and have been shown to
have significant effects on pulmonary func-
tion (37–42). Because of the interrelationship
of the cardiac and pulmonary systems, dam-
age to lung tissue is an important factor not
only in many respiratory diseases, but in
many cardiovascular diseases as well. In many
epidemiology studies with respiratory and
cardiovascular diseases, regression models
include adjustments for seasonal climate vari-
ability to isolate the contributions of air pol-
lution on the daily number of deaths or
hospital admissions for these diseases. The
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We studied exposures to higher daily maximum temperatures and concentrations of air pollutants
in Tokyo during the summer months of July and August from 1980 to 1995 and their effects on
hospital emergency transports for cardiovascular and respiratory diseases for males and females
> 65 years of age. Cardiovascular diseases were angina, cardiac insufficiency, hypertension, and
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emergency transports. Increasing daily maximum temperatures, however, were associated with
decreased hospital emergency transports for hypertension. Concentrations of nitrogen dioxide or
particulate matter ≤ 10 µm, however, were associated with daily hospital emergency transports for
angina, cardiac insufficiency, myocardial infarction, asthma, acute and chronic bronchitis, and
pneumonia. For cardiac insufﬁciency, hypertension, myocardial infarction, asthma, chronic bron-
chitis, and pneumonia, the expected daily number of emergency transports per million were
greater for males than for females. For angina and acute bronchitis, there were no differences for
the expected daily numbers of emergency transports per million between males and females. Key
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http://ehpnet1.niehs.nih.gov/docs/2001/109p355-359ye/abstract.htmlfocus of this study, however, was on the
months of July and August. We selected
these months to obtain an indication of how
prolonged exposures to both higher tempera-
tures and air pollutant concentrations could
affect hospital emergency transports for a
wide variety of diseases.
Data Characteristics and
Model Development
We obtained data on hospital emergency
transports to four Tokyo city hospitals for
each of the four cardiovascular and respiratory
diseases for the summer months of July and
August, 1980–1995, for males and females
> 65 years of age from the Tokyo Emergency
Ofﬁce. In all cases, if a record of transport had
been entered into the data collection system
for the Tokyo Emergency Ofﬁce, the patient
was transported by an emergency vehicle to
the hospital and admitted for the diagnosed
disease. The diagnosis was made by the
attending physician in the emergency room
and was based on the symptoms that the
patient presented at the time of arrival.
The daily number of hospital emergency
transports per million residents for the four
cardiovascular and respiratory diseases were
determined from population data provided
by the Ministry of Health and Welfare (4).
Because information was not available on
the percentage of males and females in this
age group from 1980 to 1995, we assumed
that 50% was male and 50% was female.
From 1980 to 1995, the percentage of the
population within the city limits of Tokyo
of males and females > 65 years of age has
increased from 7.7% (894,586) in 1980 to
13.2% (1,553,772) in 1995, even though
the total population has remained relatively
constant at 11.8 million.
To determine if there were annual trends
in the daily number of hospital emergency
transports per million for July and August,
we calculated the annual daily average num-
ber of cardiovascular disease hospital emer-
gency transports per million for each disease
for males and females (Figure 1). The data
indicated that the annual daily average num-
bers of angina and cardiac insufﬁciency hos-
pital emergency transports per million
increased for both males and females in July
and August from 1980 to 1995, whereas the
annual daily average number of hypertension
hospital emergency transports per million
appeared to decrease for males and females.
There did not appear to be much change in
the annual daily average number of myocar-
dial infarction hospital emergency transports
per million from 1980 to 1995. However,
there did appear to be signiﬁcant differences
in response between males and females for all
diseases. From these observations, we con-
cluded that classification variables were
needed in the regression model for each car-
diovascular disease to account for differences
between sexes and annual changes in the July
and August number of emergency transports
per million.
In a similar manner, we calculated the
annual daily average number of hospital
emergency transports per million for July and
August for each respiratory disease (Figure 2).
The annual daily average number of pneu-
monia and asthma hospital emergency trans-
ports per million appeared to increase for
both males and females from 1980 to 1995.
The annual daily average number of hospital
emergency transports per million for acute
and chronic bronchitis, however, appeared to
be unchanged from 1980 to 1995. There did
appear to be significant differences in
response between males and females for all
diseases. As with the cardiovascular diseases,
this behavior indicated that classification
variables were needed in the regression mod-
els for each respiratory disease to account for
differences between sexes and for annual
changes in the July and August number of
emergency transports per million.
For the daily number of emergency trans-
ports for each cardiovascular and respiratory
disease for July and August, 1980–1995, cal-
culations of means and variances of their
density functions for each disease are given in
Table 1. For the most part, these calculations
indicated that the density functions for each
disease could be assumed to be Poisson dis-
tributed. However, the means and variances
were not equal for the distributions for car-
diac insufﬁciency, asthma, and pneumonia.
As a result, there may be overdispersion in
the distributions for all diseases that will need
to be evaluated.
We obtained daily average concentrations
of air pollutants and climate variables for
Tokyo from the Japan Environment Agency.
Summary statistics for each of the variables
used in this analysis for July and August,
1980–1995 are given in Table 2. Table 3
contains the Pearson correlation coefﬁcients
among air-quality variables and Tmax. For the
study periods, these results indicate possible
correlations between NO2 and PM10, NO2
and CO, and PM10 and CO. The daily aver-
age concentrations of NO2 and CO and
Tmax temperatures increased slightly during
this time, indicating that yearly trends in
model covariates would need to be taken into
account by model calculations.
Analysis Methods
We ﬁt generalized linear models (GLMs) to
hospital emergency transport data for each
disease to determine which covariates were
signiﬁcantly associated with each of the four
cardiovascular and four respiratory diseases
(43). A GLM was used because daily num-
bers of hospital emergency transports per
million for each disease were count data.
Because only data for emergency transports
for July and August were used, confounding
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Figure 2. Daily average number of respiratory disease hospital emergency
transports per million for males (M) and females (F) > 65 years of age in Tokyo,
July–August, 1980–1995.
Figure 1. Daily average number of cardiovascular disease hospital emergency
transports per million for males (M) and females (F) > 65 years of age in Tokyo,
July–August, 1980–1995.
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Chronic bronchitis Feffects from seasonal variability were likely to
be minimal. In addition, because only data
from July and August were being used in
this study, it was assumed that the daily
number of hospital emergency transports per
million for each disease and the daily data
for each covariate within any given year were
independent of daily disease count and daily
covariate data from previous years.
Within each 2-month period in each year,
however, the daily number of hospital emer-
gency transports and the daily maximum
temperature and daily average air pollutant
concentration data for a given day can be cor-
related with the data for each of these vari-
ables from previous days. To account for
autocorrelations in the temperature and air
quality variables, we included lag times of 1–4
days for each of these covariates as additional
model variables. Generalized estimating equa-
tions that accounted for serial correlations in
the daily number of emergency transports per
million data for each disease were used to esti-
mate values for the coefﬁcients of each model
covariate (44). The correlation structure for
the covariance matrix of these generalized esti-
mating equations was assumed to be autore-
gressive. When an exchangeable correlation
structure was used, model parameter estimates
were nearly the same as those estimates given
by the autoregressive structure of the covari-
ance matrix. Based on the data given in
Figures 1 and 2, classiﬁcation variables were
also included in the models for each disease to
account for sex and for unexpected annual
trends in the daily number of hospital emer-
gency transports per million and annual
trends in Tmax and air pollutant concentra-
tions. We used PROC GENMOD from SAS
software (45) to model the number of hospi-
tal emergency transports per million for each
cardiovascular and respiratory disease for
males and females for July and August from
1980 to 1995 and to provide parameter esti-
mates for model covariates.
The model for the expected daily number
of emergency transports per million for each
cardiovascular and respiratory disease (ET) for
males and females > 65 years of age is given as
ln(ET) = Xβ , [1]
where X is a matrix that includes a column of
1s for the intercept; classification variable
columns for sex and for annual trends;
columns for the daily values for Tmax and/or
daily average concentrations for each air pol-
lutant variable with lag times of 1–4 days;
columns for interaction effects between pairs
of model covariates as indicated from the cor-
relation analysis given in Table 3; and β is
the vector of model coefficients for each
model covariate. Population changes from
1980 to 1995 have been included as an offset
or normalizing factor in this model so that
the expected daily number of hospital emer-
gency transports are expressed as the expected
daily number of hospital emergency trans-
ports per million. This makes it possible to
include changes in population for each 2-
month interval from 1980 to 1995.
To determine which covariates were sig-
niﬁcant for each disease, we constructed an
initial series of models for each of the indi-
vidual covariates and their lag effects. These
initial models for each disease also contained
classification variables for sex and annual
trends. After each round of model fitting,
insigniﬁcant model variables were eliminated
as indicated by their significance probabili-
ties or p-values, and a reduced model was
constructed for the next round of calcula-
tions. This process was repeated until the
most signiﬁcant model covariates and classi-
ﬁcation variables for each disease were iden-
tified. At this point variables that included
interactions between model covariates and
covariates and classification variables were
added to the model to determine if they
were significant. In the final models, the
effects of overdispersion in the count data
for each disease were negligible.
Results and Discussion
Table 4 provides coefﬁcient estimates for sig-
nificant model covariates, 95% confidence
intervals for these estimates, and signiﬁcance
probabilities (the column designated as
P r>| Z|) for model covariates and classiﬁca-
tion variables that were signiﬁcant contribut-
ing factors for each cardiovascular and
respiratory disease. Z is the coefficient esti-
mate for a model covariate divided by its
standard error. For the most part, same-day
exposures to either Tmax or an air pollutant
variable were significantly associated with
each disease. For chronic bronchitis, how-
ever, PM10 with a lag time of 2 days was the
most statistically signiﬁcant model covariate.
When interaction variables were included in
the models for each disease, their impacts
were negligible. Also for each disease there
was a classiﬁcation variable for sex that indi-
cated diseases for which there were differ-
ences in response between males and females.
For cardiac insufficiency, hypertension,
myocardial infarction, asthma, chronic bron-
chitis, and pneumonia, the expected daily
number of emergency transports per million
were greater for males than for females. For
angina and acute bronchitis, there were no
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Table 1. Cardiovascular and respiratory diseases studied: means and variances of the daily number of
hospital emergency transports for males and females > 65 years of age in Tokyo July–August, 1980–1995.
Males Females
Disease (ICD-9 code) Mean Variance Mean Variance
Cardiovascular diseases
Angina (413) 1.79 2.03 1.88 2.25
Cardiac insufﬁciency (428) 2.21 2.65 2.56 3.70
Hypertension (401–405) 0.96 0.97 1.54 1.61
Myocardial infarction (410) 1.93 2.05 1.35 1.43
Respiratory diseases
Acute bronchitis (466) 0.21 0.23 0.19 0.20
Asthma (493) 1.28 1.55 1.16 1.41
Chronic bronchitis (491) 0.11 0.12 0.07 0.07
Pneumonia (486) 2.33 3.75 1.86 3.14
The population in Tokyo of males and females > 65 years of age increased from 0.895 million in 1980 to 1.544 million in
1995. The total population remained relatively constant at 11.8 million from 1980 to 1995. About 50% of the population is
assumed to be male and 50% is assumed to be female.
Table 2. Summary statistics for Tmax and concentrations of NO2, O3, PM10, SO2, and CO in Tokyo, July–August,
1980–1995.
Variable No. of observations Minimum Maximum Mean (SD)
Tmax (°C) 992 17.3 36.5 28.9 (3.8)
NO2 (ppb) 988 5.3 72.2 25.4 (11.4)
O3 (ppb) 990 0.05 59.4 13.9 (9.8)
PM10 (µg/m3) 902 7.3 185.4 46.0 (27.1)
SO2 (ppb) 948 0.6 28.8 7.7 (4.8)
CO (ppb) 972 41.7 2354.2 667.2 (314.9)
Table 3. Pearson correlation coefﬁcients for Tmax and air pollution variables.
Variable Tmax NO2 O3 PM10 SO2 CO
Tmax 1.000 0.021 0.313 0.122 0.078 0.066
NO2 – 1.000 0.183 0.643 0.333 0.759
O3 – – 1.000 0.376 0.259 0.202
PM10 – – – 1.000 0.306 0.754
SO2 – – – – 1.000 0.389
CO – – – – – 1.000differences for the expected daily numbers of
emergency transports per million between
males and females. Tmax was a significant
model covariate only for pneumonia.
Concentrations of NO2 were significant
model covariates for angina, cardiac insufﬁ-
ciency, myocardial infarction, and acute
bronchitis. Concentrations of PM10 were sig-
niﬁcant model covariates for asthma, chronic
bronchitis, and pneumonia. For hyperten-
sion, the daily expected number of hospital
emergency transports per million decreased
as daily Tmax increased.
Many studies (3,25,27–34) have shown
correlations between hospital admissions for
cardiovascular diseases and CO concentra-
tions. However, the associations between the
four cardiovascular diseases and concentra-
tions of CO in these studies for July and
August in Tokyo do not appear to be very
strong. A possible explanation for this obser-
vation may be that daily average concentra-
tions of CO during the summer months
from 1980 to 1995 in Tokyo were not high
compared to other cities where correlations
between CO concentrations and cardiovas-
cular diseases were much stronger. The
mean CO concentration for Tokyo during
the study period was 0.67 ppm (SD = 0.31
ppm). Morris et al. (5), in their study of
seven U.S. cities, found average year-round
mean concentrations 3–9 times higher than
those observed in the present study. Because
of the lower mean CO concentration in
Tokyo, exposures to CO appear to have
minimal impact on the daily number of hos-
pital emergency transports for the four car-
diovascular diseases that were studied.
For this group of cardiovascular and res-
piratory diseases, even though conditions
were chosen so that daily temperatures
would be at their maximum values, expo-
sures to concentrations of NO2 and PM10
during the summer months of July and
August in Tokyo appeared to be much more
significant model covariates for many of
these diseases than were exposures to daily
maximum temperatures. However, Tmax was
a contributing factor for pneumonia.
It would be incorrect to conclude, how-
ever, that higher temperatures that may
occur as a result of climate change would not
be a significant covariate for many of these
diseases. Any time increased cardiac output
is required to return core body temperatures
to normal ranges and there are people with
cardiovascular and respiratory systems that
are not functioning at optimal levels because
of age or preexisting disease, there is an
increased probability of emergency transport
for a particular cardiovascular or respiratory
disease as daily maximum temperatures
increase. Future modeling work for these
diseases will examine the year-round
response to temperature and concentrations
of air pollutants and will require the use of
generalized additive models (14,46).
As with the heat stroke and cerebral vas-
cular disease studies, it is important to note
that the model covariates were not the same
for each disease. This is not a surprising result
because the physiologic and molecular mech-
anisms for each disease are different, even
though cardiovascular and respiratory func-
tions are highly interconnected. Even so, the
results of this study strongly suggest that each
disease should be considered separately rather
than grouped together. It should be noted
that possible factors that could be con-
founders in these studies are the smoking
habits of this age group of males and females.
Smoking habits and the presence of chronic
cardiovascular and respiratory diseases, how-
ever, should not change from day to day.
Therefore, these existing conditions should
not be confounding factors in this study (31).
Finally, it is well known that hypertension is
a precursor for congestive heart failure (car-
diac insufﬁciency in our nomenclature), but
it was not possible to account for the possible
interrelationships between these two diseases
because data on blood pressure at the time of
emergency transport and hospital admission
for individual patients were not available. 
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